Milestone Scientific (NYSE:MLSS) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS) in a research note issued on Wednesday. The brokerage set a “hold” rating on the stock.

Milestone Scientific Stock Performance

Shares of MLSS opened at $0.57 on Wednesday. Milestone Scientific has a 1 year low of $0.52 and a 1 year high of $1.35. The company has a market cap of $43.66 million, a price-to-earnings ratio of -5.70 and a beta of 0.97. The firm has a fifty day moving average of $0.65 and a 200-day moving average of $0.70.

Milestone Scientific (NYSE:MLSS) last issued its quarterly earnings data on Friday, March 29th. The company reported ($0.03) earnings per share for the quarter. Milestone Scientific had a negative net margin of 70.50% and a negative return on equity of 86.72%. The company had revenue of $2.26 million for the quarter.

Institutional Trading of Milestone Scientific

A hedge fund recently bought a new stake in Milestone Scientific stock. AE Wealth Management LLC bought a new stake in shares of Milestone Scientific Inc. (NYSE:MLSS) during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund bought 27,936 shares of the company’s stock, valued at approximately $26,000. Institutional investors and hedge funds own 5.79% of the company’s stock.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.